Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy

Rheumatology (United Kingdom)

Volumn 54, Issue 1, 2014, Pages 188-193

  Wright, Helen L ^a   Thomas, Huw B ^a   Moots, Robert J ^b   Edwards, Steven W ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Gene expression; Interferon; Neutrophil; Rheumatoid arthritis; RNA Seq

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; TRANSCRIPTOME; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; GENE EXPRESSION; GENETIC ANALYZER; GENETIC REGULATION; HUMAN; HUMAN CELL; LOW LEVEL LASER SYSTEM; NEUTROPHIL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RNA SEQUENCE; TREATMENT RESPONSE; VENOUS BLOOD; WESTERN BLOTTING;

EID: 84928728998     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu299     Document Type: Article

References (20)

1. Smith SL, Plant D, Eyre S, Barton A. The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis. Ann Rheum Dis 2013;72: 1118-24.
2. Wright HL, Moots RJ, Bucknall RC, Edwards SW. Neutrophil function in inflammation and inflammatory diseases. Rheumatology 2010;49:1618-31.
3. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011;11:519-31.
4. Wright HL, Chikura B, Bucknall RC, Moots RJ, Edwards SW. Changes in expression of membrane TNF, NF-κB activation and neutrophil apoptosis during active and resolved inflammation. Ann Rheum Dis 2011;70: 537-43.
5. Wright HL, Thomas HB, Moots RJ, Edwards SW. RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming. PLoS One 2013;8: e58598.
6. Fransen J, van Riel PL. The disease activity score and the EULAR response criteria. Clin Exp Rheumatol 2005; 23(Suppl 39):S93-9.
7. Trapnell C, Roberts A, Goff L et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012;7:562-78.
8. Anders S. HTSeq: Analysing High-Throughput Sequencing Data with Python. http://www-huber.embl.de/users/ anders/HTSeq/doc/overview.html (1 July 2014, date last accessed).
9. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010;26: 139-40.
10. Saeed AI, Bhagabati NK, Braisted JC et al. TM4 microarray software suite. Methods Enzymol 2006;411:134-93.
11. Jarvis JN, Petty HR, Tang Y et al. Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther 2006;8:R154.
12. Higgs BW, Zhu W, Richman L et al. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients. Int J Rheum Dis 2012;15:25-35.
13. Raterman HG, Vosslamber S, de Ridder S et al. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients. Arthritis Res Ther 2012;14:R95.
14. Reynier F, Petit F, Paye M et al. Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis. PLoS One 2011;6:e24828.
15. van Baarsen LG, Wijbrandts CA, Rustenburg F et al. Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment. Arthritis Res Ther 2010;12:R11.
16. van der Pouw Kraan TCTM, Wijbrandts CA, van Baarsen LG et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 2007;66:1008-14.
17. Mavragani CP, La DT, Stohl W, Crow MK. Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort. Arthritis Rheum 2010; 62:392-401.
18. Thurlings RM, Boumans M, Tekstra J et al. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. Arthritis Rheum 2010;62:3607-14.
19. Palmer C, Diehn M, Alizadeh AA, Brown PO. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 2006;7:115.
20. Henig N, Avidan N, Mandel I et al. Interferon-beta induces distinct gene expression response patterns in human monocytes versus T cells. PLoS One 2013;8:e62366.